|Mr. Richard T. Schumacher||Founder, Pres, CEO, Treasurer, Clerk, Sec. & Director||349.8k||N/A||67|
|Dr. Edmund Y. Ting Sc.D. Ph.D.||Sr. VP of Engineering||208.36k||N/A||62|
|Dr. Alexander V. Lazarev Ph.D.||VP of R&D||181.3k||N/A||52|
|Mr. Joseph L. Damasio Jr.||VP of Fin. & CFO||N/A||N/A||43|
|Dr. Nathan P. Lawrence Ph.D.||VP of Marketing & Sales||N/A||N/A||61|
Pressure BioSciences, Inc. develops pressure cycling technology (PCT) solutions in the United States. Its PCT technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, such as cells and tissues from human, animal, plant, and microbial sources. The company offers Barocycler instrumentations, including Barocycler 2320EXT, Barozyme-HT48, Barocycler NEP3229, HUB440, HUB880, and The Shredder SG3. It also distributes Constant Systems cell disruption equipment, parts, and consumables. In addition, the company offers Barocycler consumable products, such as PCT MicroTubes, PCT-MicroCaps, PCT-Micro-Pestle, and BaroFlex 8-well Processing Strips, as well as application specific kits. Pressure BioSciences, Inc. serves researchers at academic laboratories; government agencies; and biotechnology, pharmaceutical, and other life sciences institutions. The company was formerly known as Boston Biomedica, Inc. Pressure BioSciences, Inc. was founded in 1978 and is based in South Easton, Massachusetts.
Pressure BioSciences, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.